Jenya Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -56.60%
- Profit Growth -167.82%
- Ebitda -36.72%
- Net Worth -1.20%
- Total Assets 31.85%
About Jenya Biosciences
Jenya Biosciences Private Limited (JBPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 July 2013 and has a history of 11 years and seven months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Aruna Kalle and Marasanapalli Kalle serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73100TG2013PTC088933
-
Company No.
088933
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jul 2013
-
Date of AGM
29 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Jenya Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aruna Kalle
|
Director | 30-Aug-2018 | Current |
|
Marasanapalli Kalle
|
Director | 12-Jul-2013 | Current |
Financial Performance of Jenya Biosciences.
Jenya Biosciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 56.6% decrease. The company also saw a substantial fall in profitability, with a 167.82% decrease in profit. The company's net worth dipped by a decrease of 1.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jenya Biosciences?
In 2021, Jenya Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mark Therapeutics Private LimitedAruna Kalle is a mutual person
-
Aanuvamshika Innovations Private Limited
Aruna Kalle is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jenya Biosciences?
Unlock and access historical data on people associated with Jenya Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jenya Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jenya Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
